Dawes Fretzin Clinical Rea Group — Indianapolis, Indiana

Dawes Fretzin Clinical Rea Group is a clinical research site located in Indianapolis, Indiana, United States 46256.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Dawes Fretzin Clinical Rea Group has participated in 4 clinical trials with 4 currently active.

Therapeutic areas: Hidradenitis Suppurativa, Autoimmunity, Inflammation.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dawes Fretzin Clinical Rea Group?

Dawes Fretzin Clinical Rea Group has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dawes Fretzin Clinical Rea Group conducted?

Dawes Fretzin Clinical Rea Group has 4 clinical trials on record, with 4 currently active. Their work covers Hidradenitis Suppurativa, Autoimmunity, Inflammation.

Is Dawes Fretzin Clinical Rea Group accredited by Crixeo Health?

Dawes Fretzin Clinical Rea Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dawes Fretzin Clinical Rea Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.